• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hypereosinophilic Syndrome

Hypereosinophilic Syndrome - 14 Studies Found

Terminated : A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
: Hypereosinophilic Syndrome
: 2005-09-13
: Drug: imatinib mesylate Other Name: Gleevec/Glivec
Terminated : Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
: Hypereosinophilic Syndrome
: 2004-11-22
: Drug: mepolizumab Study Drug
Completed : Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
: Hypereosinophilic Syndrome
: 2016-07-14
:
  • Drug: Mepolizumab 300 mg Mepol

Active, not recruiting : Identification of New Markers in the Hypereosinophilic Syndrome
: Hypereosinophilic Syndrome
: 2012-10-22
: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms
Active, not recruiting : Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
: Hypereosinophilic Syndrome
: 2014-03-14
: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in
Completed : Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
:
  • Hypereosinophilia
  • Hypereosinophilic Syndrome

: 2004-07-07
: Drug: mepolizumab
Available : This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma
: Hypereosinophilic Syndrome
: 2005-10-25
: Drug: Mepolizumab open label investigational product
Completed : Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia
  • <
    : 2008-11-06
    : Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c
Completed : Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia (CEL)<
    : 2006-01-12
    : Drug: STI571
Completed : Steroid Treatment for Hypereosinophilic Syndrome
: Hypereosinophilia
: 2012-02-01
: Drug: Corticosteroids
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.